Contact Us

Trasylol
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date of surgery: 

Have you (or injured party) experienced any of the following:




Did you (or injured party) require dialysis?

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Trasylol

Bayer Settling Trasylol Lawsuits, Report Says

Aug 18, 2010
| Parker Waichman LLP
About 150 Trasylol lawsuits have been settled by Bayer AG for at least $60 million, according to Bloomberg News. According to three anonymous...

Trasylol Lawsuit Claims Bayer Failed to Warn of Side Effects

Sep 4, 2009
| Parker Waichman LLP
Bayer has been sued over Trasylol, a drug used to prevent bleeding during heart bypass surgery that was withdrawn from the market in  May...

Another Trasylol Study Finds Cheaper Drugs Less Risky

Dec 4, 2008
| Parker Waichman LLP
Another study is questioning the safety of Trasylol (aprotinin).   Trasylol, a drug made by Bayer for use in cardiac surgery, was withdrawn...

Trasylol Named in Two Lawsuits

Oct 10, 2008
| Parker Waichman LLP
Trasylol, Bayer AG's now-withdrawn anti-bleeding medication, is the subject in two Illinois lawsuits.  One of the plaintiffs claims Trasylol was...

Trasylol Gone for Good

May 15, 2008
| Parker Waichman LLP
Trasylol is being removed from the market for good.  Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart...

Trasylol Named in 78 Lawsuits, Bayer Says

Apr 28, 2008
| Parker Waichman LLP
Bayer AG has been hit with 78 lawsuits over the drug Trasylol.  In November, Bayer suspended Trasylol sales after a Canadian study linked it to...

More Trasylol Studies -- One Previously Withheld by Bayer -- Confirm Death Risks

Feb 21, 2008
| Parker Waichman LLP
Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug.  Trasylol,...

FDA Trasylol Failure Could Have Killed Thousands, Researcher Says

Feb 15, 2008
| Parker Waichman LLP
Trasylol, a defective drug manufactured by Bayer AG, may have killed 22,000 people before it was pulled from the market last year.  Trasylol was...

Trasylol Drug Combo Linked to Deaths

Feb 12, 2008
| Parker Waichman LLP
A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate.  According to British...

Trasylol Sales Suspended After Canadian Study Links Drug to Sudden Death Risk

Nov 26, 2007
| Parker Waichman LLP
Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a...

Page 1/4 [first] [prev] 1 2 3 4 [next] [last]